Patents Assigned to BreasaGen Limited
  • Haemopoietic growth factor antagonists and uses therefor
    Patent number: 6322791
    Abstract: The present invention relates generally to variant recombinant forms of haemopoietic growth factors useful as antagonists to the corresponding native haemopoietic growth factor and their use in ameliorating aberrant effects caused by the native molecules and in the treatment of tumours and cancers and inflammation.
    Type: Grant
    Filed: May 28, 1998
    Date of Patent: November 27, 2001
    Assignee: BreasaGen Limited
    Inventors: Mathew Alexander Vadas, Angel Francisco Lopez, Mary Francis Shannon, Keat-Chye Cheah, Carol Ruth Senn, Stan Bastiras, Allan Robins